AWU-20258-17649
3 vaccinations
5 coded responses
34 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 840 / UT
- Registered
- 2021-02-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-10
Registered in v-safe
-
2021-02-10
Dose 1 — Pfizer-BioNTech
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
-
2021-02-14
Survey response — days 1–6 daily, dose 1MedDRA: Headache — Feeling: Good · HeadacheFree text: I got a headache yesterday after I had already reported as well.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-15
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: GoodFree text: No HA so far today. Last two days HAs may have been caused by something else.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-16
- 2021-02-17
- 2021-02-24
-
2021-03-03
Dose 2 — Pfizer-BioNTech
- 2021-03-03
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Body temperature increased — Feeling: Good · Site: PainFree text: Last night my highest oral temperature of 100.7 F. I have been afebrile all day today. I have had no other S/S today.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-06-02
- 2021-09-01
-
2021-12-17
Dose 3 — Pfizer-BioNTech
-
2021-12-22
Survey response — days 1–6 daily, dose 3MedDRA: Erythema, Pain, Product administered at inappropriate site, Swelling — Feeling: Good · Site: Redness, Swelling, Itching · Rash, not including the immediate area around the injection siteFree text: Day 2 & 3 after shot #3 (booster) I had moderate to severe redness, swelling, and mild pain. Never had this before after dose # 1 & 2. Pharmacy tech who administered booster did so in incorrect location, about 2 inches below deltoid muscle!MedDRA releases: 2024-11 · check-in free text available
- 2021-12-24
- 2021-12-31
- 2022-01-07
- 2022-01-14
-
2022-01-21
Survey response — day 35, dose 3MedDRA: Urinary tract infection — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Symptoms: I have a UTI. So not related to COVID that I can imagine. · Healthcare visit (other): Getting Rx for UTIMedDRA releases: 2024-11 · check-in free text available
-
2022-01-21
Report sent to call center — day 35, dose 3Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-01-26
- 2022-01-28
- 2022-03-18
- 2022-06-17
- 2022-12-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-10 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech | |
| 3 | 2021-12-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): I got a headache yesterday after I had already reported as well.
Systemic reaction (other): No HA so far today. Last two days HAs may have been caused by something else.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Last night my highest oral temperature of 100.7 F. I have been afebrile all day today. I have had no other S/S today.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Day 2 & 3 after shot #3 (booster) I had moderate to severe redness, swelling, and mild pain. Never had this before after dose # 1 & 2. Pharmacy tech who administered booster did so in incorrect location, about 2 inches below deltoid muscle!
Release 11 — day 35, dose 3
Symptoms: I have a UTI. So not related to COVID that I can imagine.
Healthcare visit (other): Getting Rx for UTI
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Urinary tract infection | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Body temperature increased | ✓ | ✓ | ✓ |
| SRO | Erythema | · | · | ✓ |
| SRO | Headache | ✓ | ✓ | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Product administered at inappropriate site | · | · | ✓ |
| SRO | Swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release